Peptide-transporter 1 (PEPT1) is a brush-border transporter of di- and tri-peptides, located on L-cells of the small intestine and colon
#Ozempic #NovoNordisk #DiabetesCare #GLP1 #IndianPharma #HealthcareInnovation #PharmaNews #DiabetesManagement #IndiaHealthcare To view or add a comment, sign in We are proud to share an important milestone for Medilink Healthcare
Demand for Mounjaro and later Zepbound dramatically exceeded supply as the medications gained attention for their weight loss effectiveness
Sodium-glucose cotransporter 2 inhibitors (SGLT2-I) and glucagon-like peptide-1 receptor agonists (GLP-1RA) have been shown to reduce cardiovascular risk and mortality in patients with type 2 diabetes mellitus (T2D) and established cardiovascular disease, yet remain underutilized in clinical practice
Dosing Schedules: Wegovy vs Ozempic Standard dosing and titration Both medications are started at low doses and increased gradually to reduce gastrointestinal side effects
The jump from 1mg to 4mg, nearly doubling the weight loss percentage, likely represents the addition of meaningful glucagon receptor engagement
